Venus Medtech (Hangzhou) Inc. VMTHF
0.13 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.4219 Day range 0.4219
0.1323 52-week range 0.4219
- YTD
- -50.65%
- 1 year
- -57.46%
Financial health
Altman Z-Score
-0.06 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -2.1×
FY 2019 5y median -2.1× FY 2025
P/S 2.7×
FY 2019 5y median 2.7× FY 2025
P/B 0.5×
FY 2019 5y median 0.5× FY 2025
P/FCF -2.5×
FY 2019 5y median -2.5× FY 2025
EV/EBITDA -3.6×
FY 2019 5y median -3.6× FY 2025
EV/Sales 2.9×
FY 2019 5y median 2.9× FY 2025
FCF Yield -40.5%
FY 2019 5y median -40.5% FY 2025
Profitability
Gross Margin 45.9%
FY 2019 5y median 78.0% FY 2025
Operating Margin -112.8%
FY 2019 5y median -112.8% FY 2025
Net Margin -132.9%
FY 2019 5y median -143.2% FY 2025
ROE -22.5%
FY 2019 5y median -24.1% FY 2025
ROIC -14.5%
FY 2019 5y median -12.5% FY 2025
ROA -15.8%
FY 2019 5y median -15.9% FY 2025
Growth (YoY)
Revenue -36.5%
FY 2019 FY 2025
Operating Income 2.7%
FY 2019 FY 2025
EPS (diluted) 44.2%
FY 2019 FY 2025
Free Cash Flow -1764.0%
FY 2019 FY 2025
Financial Health
Current Ratio 2.8×
FY 2019 5y median 2.8× FY 2025
Quick Ratio 2.4×
FY 2019 5y median 2.4× FY 2025
Debt / Equity 0.1×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2019 5y median -0.1× FY 2025
Interest Coverage -19.2×
FY 2019 5y median -19.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
